Timely Diagnosis of Alzheimer Disease is organized by CME Institute of Physicians Postgraduate Press, Inc. (PPP).
Activity opens: 05/26/2022
Activity expires: 06/02/2024
Overview
Early-stage diagnosis of Alzheimer disease leads to prompt treatment initiation and better patient QoL. Learn about new guidelines and technology advances and what’s on the horizon from authorities in the field.
Learning Objectives
• Facilitate prompt treatment initiation for patients who have early-stage AD
• Discuss the potential use of current and emerging agents focused on reducing disease progression with patients and their care partners
Additional details will be posted as soon as information is available.
Accreditation Statement:
The CME Institute of Physicians Postgraduate Press, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
The CME Institute of Physicians Postgraduate Press, Inc., designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Note: The American Nurses Credentialing Center (ANCC) and the American Academy of Physician Assistants (AAPA) accept certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
To obtain credit for this activity, study the material and complete the CME Posttest and Evaluation.
Available Credit:
0.50 AMA PRA Category 1 Credit™
0.50 Participation
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved